Electronic Health Records for Health Promotion
The purpose of this study is to determine whether personally controlled electronic health records can be used for health promotion in a workplace setting.
|Study Design:||Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Single Blind
Primary Purpose: Prevention
|Official Title:||Health Promotion in the Workplace Using Personally Controlled Health Records|
- - Rate of influenza immunization among subjects
- Change in knowledge, attitutes, and beliefs regarding influenza and influenza immunization.
- Changes in health behaviors around influenza (e.g. hand washing and cough etiquette).
- General health outcomes related to respiratory illnesses (e.g. number of influenza-like illnesses, number of physician visits, number of missed work days).
- Rate of influenza immunization among subject household members.
|Study Start Date:||October 2005|
|Study Completion Date:||May 2006|
In response to the call for research of the new Health Protection Research Initiative at the Centers for Disease Control and Prevention (CDC), we propose to adapt newly mature informatics technology to shift the paradigm for health alerting and health promotion in the workplace. The goal is to firmly ground these activities on real time information collected from and delivered to employees, in an interactive, secure, electronic environment. We will study influenza prevention and control, an archetype of public health practice requiring surveillance, communication, and timely influence of health-related behaviors. Complex information gleaned from surveillance will be processed, translated and provided to employees. The goal is to provide employees with timely, individualized health promotion messages to improve their knowledge, attitudes and beliefs regarding influenza and to increase the rate of seasonal influenza immunization for them and their household members. The approach will be evaluated in a group randomized design at several worksites of a major corporation.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00142077
|United States, Massachusetts|
|Children's Hospital Boston|
|Boston, Massachusetts, United States, 02116|
|Principal Investigator:||Kenneth D Mandl, MD, MPH||Children's Hospital Boston|